Непосредственные результаты хирургического и эндоваскулярного лечения больных ишемической болезнью сердца: периоперационные осложнения, факторы риска, прогноз
Авторы:
Организация:
Научный центр сердечно-сосудистой хирургии им. А. Н. Бакулева (дир. – академик РАН Л. А. Бокерия), Москва
Для корреспонденции: Сведения доступны для зарегистрированных пользователей.
Тип статьи: Актуальные вопросы диагностики и лечения ишемической болезни сердца
Ключевые слова:
Скачать (Download)
Аннотация
В исследование включены 450 пациентов с ишемической болезнью сердца, в возрасте от 29 до 80 лет (в среднем 53±8,3 года), перенесших операцию реваскуляризации миокарда. Пациенты были разделены на две группы в зависимости от метода реваскуляризации миокарда. В первую группу вошли больные после аортокоронарного шунтирования (170 человек), во вторую – после стентирования коронарных артерий (280 человек). В результате исследования определены факторы риска развития сердечной недостаточности, острых тромбозов стентов и шунтов, неврологических осложнений, нарушений ритма сердца и летальных исходов.Литература
1. Бокерия, Л. А. Сердечно-сосудистые заболевания в Российской Федерации на рубеже веков: смертность, распространенность, факторы риска / Л. А. Бокерия, И. Н. Ступаков, И. В. Самородская, Ю. М. Ботнарь // Бюллетень НЦССХ им. А. Н. Бакулева РАМН. – 2007. – № 5.2. Какучая, Т. Т. Фибрилляция предсердий после АКШ: прогностические факторы, особенности диагностики и лечения: дис. … канд. мед. наук / Т. Т. Какучая. – М., 2004.
3. Лобачева, Г. В. Факторы риска развития после- операционных осложнений после операций на открытом сердце: дис. … д-ра мед. наук / Г. В. Лобачева. – М., 2000.
4. Фарафонова, Т. Н. Нарушения ритма сердца в ранние сроки после операции коронарного шунтирования на работающем сердце: дис. … канд. мед. наук / Т. Н. Фарафонова. – М., 2006.
5. Шумков, К. В. Сочетанное немедикаментозное лечение желудочковых аритмий у больных ИБС: дис. … канд. мед. наук / К. В. Шумков. – М., 2005.
6. Barner, H. B. Operative treatment of coronary atherosclerosis / H. B. Barner // Ann. Thorac. Surg. – 2008. – Vol. 85. – P. 1473–1482.
7. Bittl, J. A. Advances in coronary angioplasty / J. A. Bittl // N. Engl. J. Med. – 1996. – Vol. 335. – P. 1290–1302.
8. Booth, J. Randomized, controlled trial of coronary artery bypass surgery versus percutaneous coronary intervention in patients with multivessel coronary artery disease: six-year follow-up from the Stent or Surgery Trial (SoS) / J. Booth, T. Clayton, J. Pepper et al. // Circulation. – 2008. – Vol. 118. – P. 381–388.
9. Bravata, D. M. Systematic review: the comparative effectiveness of percutaneous coronary interventions and coronary artery bypass graft surgery / D. M. Bravata, A. L. Gienger, K. M. McDonald et al. // Ann. Intern. Med. – 2007. – Vol. 147. – P. 703–716.
10. Brener, S. J. Comparison of percutaneous versus surgical revascularization of severe unprotected left main coronary stenosis in matched patients / S. J. Brener, J. M. Galla, R. Bryant III et al. // Am. J. Cardiol. – 2008. – Vol. 101. – P. 169–172.
11. Briguori, C. Comparison of coronary drug-eluting stents versus coronary artery bypass grafting in patients with diabetes mellitus / C. Briguori, G. Condorelli, F. Airoldi et al. // Am. J. Cardiol. – 2007. – Vol. 99. – P. 779–784.
12. Buszman, P. E. Acute and late outcomes of unprotected left main stenting in comparison with surgical revascularization / P. E. Buszman, S. R. Kiesz, A. Bochenek et al. // J. Am. Coll. Cardiol. – 2008. – Vol. 51. – P. 538–545.
13. Buxton, B. F. Bilateral internal thoracic artery grafting may improve outcome of coronary artery surgery: risk-adjusted survival / B. F. Buxton, M. Komeda, J. A. Fuller, I. Gordon // Circulation. – 1998. – Vol. 98 (Suppl. II-1).
14. Chieffo, A. Percutaneous treatment with drug-eluting stent implantation versus bypass surgery for unprotected left main stenosis: a single-center experience / A. Chieffo, N. Morici, F. Maisano et al. // Circulation. – 2006. – Vol. 113. – P. 2542–2547.
15. Cohen, D. Three-year SYNTAX results extend CABG advantage to intermediate-risk patients / D. Cohen, A. P. Kappetein. – 2010 // http://www.The heart.org
16. Colombo, A. 365-day follow-up of the RAVEL study: a randomized study with sirolimus-eluting BX Velocity balloon-expandable stent / A. Colombo, J. Fajadet, G. Schuler // Eur. Heart J. – 2002. – Vol. 4. – P. 264 (Suppl. A).
17. Daemen, J. Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: a meta-analysis with 5-year patient-level data from the ARTS, ERACI-II, MASS-II, and SoS trials/ J. Daemen, E. Boersma, M. Flather et al. // Circulation. – 2008. – Vol. 118. – P. 1146–1154.
18. Fajadet, J. 210-day follow-up of the RAVEL Study: A randomized study with the sirolimus-eluting BX Velocity balloon-expandable stent in the treatment of patients with de novo native coronary artery lesions / J. Fajadet, M. Perin, E. Hayashi // J. Am. Coll. Cardiol. – 2002. – Vol. 39. – P. 250 (Suppl. A).
19. Flynn, M. Fast-tracking revisited: routine cardiac surgical patients need minimal intensive care / M. Flynn, S. Reddy, W. Shepherd et al. // Eur. J. Cardiothorac. Surg. – 2004. – Vol. 25. – P. 116–122.
20. Grocott, H. P. Cognitive dysfunction after cardiac surgery: revisiting etiology / H. P. Grocott, H. M. Homi, F. Puskas // Semin. Cardiothorac. Vasc. Anesth. – 2005. – Vol. 9, № 2. – P. 123–129.
21. Grьntzig, A. Transluminal dilatation of coronaryartery stenosis / A. Grьntzig // Lancet. – 1978. – Vol. 1. – P. 263.
22. Hannan, E. L. Drug-eluting stents vs. coronaryartery bypass grafting in multivessel coronary disease / E. L. Hannan, C. Wu, G. Walford et al. // N. Engl. J. Med. – 2008. – Vol. 358. – P. 331–341.
23. Herz, I. Drug-eluting stents versus bilateral internal thoracic grafting for multivessel coronary disease / I. Herz, Y. Moshkovitz, D. Loberman et al. // Ann. Thorac. Surg. – 2005. – Vol. 80. – P. 2086–2090.
24. Holmes, D. R. Jr. Moses: Analysis of 1-year clinical outcomes in the SIRIUS trial / D. R. Holmes Jr, M. B. Leon // Circulation. – 2004. – Vol. 110, № 5. – P. 508–514.
25. Janssen, D. P. Preoperative prediction of prolonged stay in the intensive care unit for coronary bypass surgery / D. P. Janssen, L. Noyez, C. Wouters, R. M. Brouwer // Eur. J. Cardiothorac. Surg. – 2004. – Vol. 25. – P. 203–207.
26. Javaid, A. Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with drug-eluting stents for patients with multivessel coronary artery disease / A. Javaid, D. H. Steinberg, A. N. Buch et al. // Circulation. – 2007. – Vol. 116. – P. 200 (Suppl. 1).
27. Kaluza, G. L. Inhibition of restenosis with a paclitaxel- eluting, polymer-free coronary stent: the European evaLUation of pacliTaxel Eluting Stent (ELUTES) trial / G. L. Kaluza, A. H. Gershlick // Am. J. Cardiol. – 2004. – Vol. 94, № 2. – P. 99–201.
28. Lagerqvist, B. Stent thrombosis in Sweden: a report from the Swedish coronary angiography and angioplasty registry / B. Lagerqvist, J. Carlsson, O. Frцbert et al. // Circ. Cardiovasc. Interv. – 2009. – Vol. 2. – P. 401–408.
29. Lee, M. S. Comparison of bypass surgery with drugeluting stents for diabetic patients with multivessel disease / M. S. Lee, F. Jamal, G. Kedia et al. // Int. J. Cardiol. – 2007. – Vol. 123. – P. 34–42.
30. Lee, M. S. Comparison of coronary artery bypass surgery with percutaneous coronary intervention with drug-eluting stents for unprotected left main coronary artery disease / M. S. Lee, N. Kapoor, F. Jamal et al. // J. Am. Coll. Cardiol. – 2006. – Vol. 47. – P. 864–870.
31. Lemos, P. A. Early outcome after sirolimus-eluting stent implantation in patients with acute coronary syndromes: insights from the Rapamycin – Eluting Stent Evaluation At Rotterdam Cardiology Hospital-(RESEARCH) registry / P. A. Lemos, C. H. Lee, M. Degertekin et al. // J. Am. Coll. Cardiol. – 2003. – Vol. 41. – P. 2093–2099.
32. McKhann, G. M. Encephalopathy and stroke after coronary artery bypass grafting: incidence, consequences, and prediction / G. M. McKhann, M. A. Grega, L. M. Borowicz Jr et al. // Arch. Neurol. – 2002. – Vol. 59, № 9. – P. 1422–1428.
33. Mora, Ch. T. The effect of temperature management during cardiopulmonary bypass on neurologic and neuropsychologic outcomes in patient undergoing coronar revascularization / Ch. T. Mora, M. B. Henson, W. S. Weintraub et al. // J. Thorac. Cardiovasc. Surg. – 1996. – Vol. 112. – P. 514–522.
34. Palmerini, T. A comparison between coronary artery bypass grafting surgery and drug eluting stent for the treatment of unprotected left main coronary artery disease in elderly patients (aged >or=75 years) / T. Palmerini, F. Barlocco, A. Santarelli et al. // Eur. Heart J. – 2007. – Vol. 28. – P. 2714–2719.
35. Sanmartin, M. Comparison of drug-eluting stents versus surgery for unprotected left main coronary artery disease / M. Sanmartin, J. A. Baz, R. Claro et al. // Am. J. Cardiol. – 2007. – Vol. 100. – P. 970–973.
36. Schofer, J. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomized controlled trial (E-SIRIUS) / J. Schofer, M. Schluter // Am. J. Ther. – 2004. – Vol. 11, № 3. – P. 218–228.
37. Serruys, P. W. Coronary-artery stents / P. W. Serruys, M. J. B. Kutryk, A. T. L. Ong // N. Engl. J. Med. – 2006. – Vol. 354. – P. 483–495.
38. Serruys, P. W. Percutaneous coronary intervention versus coronary artery bypass grafting for sever coronary artery disease / P. W. Serruys, M. C. Morice, A. P. Kappetein et al. // New Engl. J. Med. – 2009. – Vol. 360, № 10.
39. Serruys, P. W. Three-year follow-up of the ARTSII– sirolimus-eluting stents for the treatment of patients with multivessel coronary artery disease / P. W. Serruys, J. Daemen, M.-C. Morice et al. // EuroIntervention. – 2007. – Vol. 3. – P. 450–459.
40. Smith, S. C. Jr. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention) / S. C. Smith Jr, T. E. Feldman, J. W. Hirshfeld Jr et al. // J. Am. Coll. Cardiol. – 2006. – Vol. 47. – P. 216–235.
41. Stettler, C. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis / C. Stettler, S. Wandel, S. Allemann et al. // Lancet. – 2007. – Vol. 370. – P. 937–948.
42. Tavilla, G. Long-term follow-up of coronary artery bypass grafting in three-vessel disease using exclusively pedicled bilateral internal thoracic and right gastroepiploic arteries / G. Tavilla, A. P. Kappetein, J. Braun et al. // Ann. Thorac. Surg. – 2004. – Vol. 77. – P. 794–799.
43. Wijns, W. ESC/EACTS Guidelines on myocardial revascularization 2010 / W. Wijns et al. // Eur. Heart J. – 2010. – Vol. 10, № 31. – P. 2501–2555.
44. Yang, Z. K. Coronary artery bypass surgery versus percutaneous coronary intervention with drugeluting stent implantation in patients with multivessel coronary disease / Z. K. Yang, W. F. Shen, R. Y. Zhang et al. // J. Interv. Cardiol. – 2007. – Vol. 20. – P. 10–16.
